Craig Seamands
Psychiatry · Council Bluffs, IANPI 1629128624
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 229 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 26.3% of the total. Among psychiatry clinicians in IA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 229 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sunovion Pharmaceuticals Inc.$1K
- Alkermes, Inc.$680
- Johnson & Johnson$595
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$560
- Otsuka America Pharmaceutical, Inc.$432
- AbbVie$339
- plus $439 from 8 others
What the payments were for
- Food & beverage$4,05198%
- Education$822%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sunovion Pharmaceuticals Inc. | 57 | $1,089 |
| Alkermes, Inc. | 50 | $680 |
| Johnson & Johnson | 30 | $595 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $560 |
| Otsuka America Pharmaceutical, Inc. | 31 | $432 |
| AbbVie | 15 | $339 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $126 |
| Neurocrine Biosciences, Inc. | 1 | $103 |
| Vertical Pharmaceuticals, LLC | 5 | $79 |
| Shire North American Group Inc | 4 | $61 |
| Tris Pharma Inc | 1 | $21 |
| Neuronetics, Inc. | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$500
- CAPLYTA$203
- ARISTADA INITIO$125
- VRAYLAR$121
- INGREZZA$103
How this compares
$4,133 in reported general payments places this provider in the 90th percentile of 245 psychiatry providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 14 | $123 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Council Bluffs
- Harmit SinghCouncil Bluffs$4K
- Alfred OngesaCouncil Bluffs$3K
- Charles JennischUrbandale$949K
- Manmohan SinghDes Moines$408K
- Jimmy MascaroOttumwa$361K
- Alan WhittersCedar Rapids$170K
- Donald BlackIowa City$19K
- William CoryellIowa City$18K
- Randall KavalierWest Des Moines$15K
- Dwight SchroederCedar Rapids$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.